Boc-L-Valine

Online Inquiry

CAT#CP02207
CAS13734-41-3
Synonyms/AliasBoc-L-valine;13734-41-3;Boc-Val-OH;N-(tert-Butoxycarbonyl)-L-valine;(S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoicacid;N-Boc-L-valine;(S)-2-(Boc-amino)-3-methylbutyricacid;tert-Butoxycarbonylvaline;N-tert-Butoxycarbonyl-L-valine;N-tert-Butoxycarbonylvaline;tert-Butoxycarbonyl-L-valine;n-(tert-butoxycarbonyl)-l-valin;N-tert-Butyloxycarbonyl-L-valine;SZXBQTSZISFIAO-ZETCQYMHSA-N;MFCD00065605;SBB028543;Boc-L-Val-OH;(TERT-BUTOXYCARBONYL)-L-VALINE;(2S)-2-[(tert-butoxycarbonyl)amino]-3-methylbutanoicacid;N-((1,1-Dimethylethoxy)carbonyl)-L-valine;N-[(1,1-Dimethylethoxy)carbonyl]-L-valine;L-Valine,N-[(1,1-dimethylethoxy)carbonyl]-;L-Valine,N-((1,1-dimethylethoxy)carbonyl)-;N-alpha-t-BOC-L-VALINE;(2S)-2-[(tert-butoxy)carbonylamino]-3-methylbutanoicacid
M.F/FormulaC10H19NO4
M.W/Mr.217.3
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...

  KAI-1455, a ε-protein kinase C activator in Phase I testing for the treatment of ischemia-induced reperfusion i ...

 Ramoplanin is a new kind of glycopeptide antibiotics, which can inhibit the biosynthesis of the cell walls of gr ...

 Myristoyl pentapeptide-7, a cosmetic peptide, is a synthetic peptide containing lysine and threonine residues, w ...

 The thymopentin is a small peptide consisting of 5 amino acid residues (Arg-Lys-Asp-Val-Tyr) from thymosin. It h ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.